Status:

COMPLETED

Type 1 Diabetes Telemedicine

Lead Sponsor:

University of California, Davis

Conditions:

Diabetes Mellitus, Type 1

Eligibility:

All Genders

1-17 years

Phase:

NA

Brief Summary

At the conclusion of this project, investigators will have assessed the effectiveness of home-based telemedicine for improving multiple important clinical and patient-centered outcomes in a high-risk ...

Eligibility Criteria

Inclusion

  • age 1-17 years
  • known diagnosis of T1D
  • \>1 prior visit to the UC Davis Pediatric Endocrinology clinic (to avoid enrolling newly diagnosed patients)
  • suboptimal glycemic control, defined as most recent hemoglobin A1C level of \>8%
  • access to the internet via a device with video and audio capability (e.g. computer, tablet, mobile phone)
  • ability to connect their home glucose meter to an internet-capable device via Bluetooth or physical cable for the purpose of data uploading.

Exclusion

  • Patients and parents whose primary language is not English
  • Patients who have Western Health Advantage health insurance

Key Trial Info

Start Date :

November 27 2017

Trial Type :

INTERVENTIONAL

Allocation :

ACTUAL

End Date :

October 31 2019

Estimated Enrollment :

59 Patients enrolled

Trial Details

Trial ID

NCT03374462

Start Date

November 27 2017

End Date

October 31 2019

Last Update

February 21 2020

Active Locations (1)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 1 (1 locations)

1

University of California-Davis

Sacramento, California, United States, 95817

Type 1 Diabetes Telemedicine | DecenTrialz